A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
暂无分享,去创建一个
Michael L. Wang | R. Orlowski | Lei Feng | Sheeba K. Thomas | J. Shah | D. Weber | E. Manasanch | K. Patel | R. Alexanian | Hans C. Lee | Rebecca Lu | Ashley N. Morphey | Brandon N. Crumpton | Lei Feng | Ashley Morphey